1.Safety and efficacy analysis of hepatic artery infusion chemotherapy combined with immune targeted therapy for single CNLC Ⅰb hepatocellular carcinoma
Haixiang XIE ; Chuangye HAN ; Kai PENG ; Xinping YE ; Guangzhi ZHU ; Zhiming ZENG ; Kai HU ; Hong YANG ; Liling LONG ; Lin TAO ; Zili LYU ; Tao PENG
Chinese Journal of Hepatobiliary Surgery 2023;29(1):28-33
Objective:To investigate the safety and efficacy of FOLFOX (5-fluorouracil + calcium folinate + oxaliplatin) hepatic arterial infusion chemotherapy (FOLFOX-HAIC) combined with immune and targeted therapy as triple combination therapy for patients with single China Liver Cancer Staging (CNLC) Ⅰb hepatocellular carcinoma.Methods:A total of 20 patients with single CNLC Ⅰb hepatocellular carcinoma who received FOLFOX-HAIC combined with immune and targeted therapy as triple combination therapy in the First Affiliated Hospital of Guangxi Medical University from October 2021 to August 2022 were included. The clinical data of all patients was retrospectively analyzed. There were 18 males and 2 females, with the age of (55.1±9.9) years. Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 and Modified Response Evaluation Criteria in Solid Tumors (mRECIST) were used to evaluate the efficacy of FOLFOX-HAIC combined with immune and targeted therapy, and the clinical safety of triple combination therapy was evaluated by common terminology criteria for adverse events 4.0.Results:According to RECIST 1.1, objective response rate of 20 patients was 70.0% (14/20) and disease control rate was 100.0% (20/20) after 2 cycles of treatment (one cycle of FOLFOX-HAIC plus programmed death-1 antibody). According to mRECIST, objective response rate was 90.0% (18/20) and the disease control rate was 100.0% (20/20) after 2 cycles of treatment. Following the treatment, 12 patients (60.0%) received liver tumor resection, and all of them achieved R 0 resection, 2 patients (10.0%) received radiotherapy, 3 patients (15.0%) stopped drug treatment for surgery, 2 patients (10.0%) refused surgery, and 1 patient (5.0%) died of multiple organ failure caused by immune hepatitis. According to pathological results, 3 patients (25.0%, 3/12) achieved pathological complete response, and 4 patients (33.3%, 4/12) achieved major pathological response. In the safety evaluation, the overall incidence of adverse events was 100.0% (20/20). Seven patients (35.0%) had grade 3 adverse events and 1 patient (5.0%) died of multiple organ failure due to immune hepatitis (grade 5). Grade 1-3 adverse events could be relieved after symptomatic treatment. Conclusion:The triple combination therapy of FOLFOX-HAIC combined with immune and targeted therapy is safe and has high objective response rate and disease control rate, which could be a new strategy for the neoadjuvant treatment of hepatocellular carcinoma.
2.Comparison of clinical effects of a novel stent assisted intestinal bypass and temporary loop ileostomy in laparoscopic low anterior resection of rectal cancer
Liushiyang XU ; Shiyu HU ; Wanbo HUANG ; Jianming XIE ; Jiabin YANG ; Yongfang YIN ; Haixiang DING ; Zhilong YAN
Chinese Journal of General Surgery 2023;38(6):401-406
Objective:To compare the clinical value of stent assisted intestinal bypass and temporary loop ileostomy in laparoscopic low anterior resection of rectal cancer.Method:In this retrospective analysis, 57 patients undergoing laparoscopic low anterior resection for rectal cancer in the First Affiliated Hospital of Ningbo University from Jan 2020 to Jan 2022 were divided into intestinal bypass group (36 cases) and loop ileostomy group (21 cases).Result:There were no significant differences in postoperative GI function recovery and postoperative complication rate between the two groups (all P>0.05). The levels of albumin, prealbumin and hemoglobin in the intestinal bypass group were better than those in the ileostomy group when evaluated on 3rd months after operation [(40.5±2.3) g/L vs. (38.1±2.6)g/L、(26.4±2.7)mg/dl vs. (24.5±2.0)mg/dl、(137.6±5.9) g/L vs. (134.0±7.0) g/L, t=3.605、2.743、2.085, all P<0.05]. Hospital expenses of the intestinal bypass group was lower [(571 000±7 500) yuan vs. (69 300±9 100) yuan, t=-5.477, P<0.05]. Conclusion:Compared with traditional ileostomy, the stent assisted intestinal bypass reduces trauma with lower expenses and improves patients' status after laparoscopic low anterior resection for rectal cancer.
3.Design and Development of Cloud Platform of Emergency COVID-19 Nucleic Acid Detection.
Haifang LOU ; Haixiang WU ; Juan HU ; Qiaoye ZHANG ; Xufan TANG ; Fei WU ; Zhiwen YAN ; Ren CHEN
Chinese Journal of Medical Instrumentation 2022;46(2):172-175
According to the characteristics of short time and large amount of samples for out of hospital emergency nucleic acid detection, this study introduces an out of hospital emergency nucleic acid detection cloud platform system, which realizes the functions of rapid identification of the detected person and one-to-one correspondence with the samples, and real-time upload of the detection results to Zhejiang Government service network for quick viewing and statistics, so as to complete the task of national nucleic acid screening efficiently and accurately that we must provide information support.
COVID-19
;
Cloud Computing
;
Humans
;
Nucleic Acids
;
SARS-CoV-2
4.Research Progress of Proteolysis Targeting Chimeria in NSCLC Therapy.
Lin JIANG ; Jingbo ZHANG ; Jiaqi HU ; Haixiang QI ; Heng XU
Chinese Journal of Lung Cancer 2022;25(7):477-481
Proteolysis targeting chimeria (PROTAC) degrades target proteins by utilizing the ubiquitin-proteasome pathway, subverting the concept of traditional small molecule inhibitors. Among the common mutation targets of non-small cell lung cancer (NSCLC), PROTAC technology has successfully achieved the effective degradation of kirsten rat sarcoma viral oncogene homolog (KRAS), epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK ) and other proteins in preclinical studies. PROTAC drugs with their unique event-driven advantages, are expected to overcome acquired drug resistance caused by small molecule inhibitors and show good therapeutic potential for undruggable targets, thereby providing a new strategy for the treatment of NSCLC.
.
Carcinoma, Non-Small-Cell Lung/pathology*
;
Humans
;
Lung Neoplasms/pathology*
;
Mutation
;
Protein Kinase Inhibitors/therapeutic use*
;
Proteolysis
;
Proto-Oncogene Proteins p21(ras)/genetics*
5.Construction and application of central monitoring system of hospital ward monitor
Haifang LOU ; Haixiang WU ; Juan HU ; Lei LING ; Qiaoye ZHANG ; Xufan TANG ; Fei WU ; Zhiwen YAN ; Ren CHEN
Chinese Journal of Hospital Administration 2021;37(4):300-302
The authors introduced the construction of the central monitoring system of bedside monitor in a hospital, and introduced its software and hardware design scheme and function in detail. The implementation of the system guaranteed the medical safety, reduced the workload of medical staff, improved the work efficiency, and had the characteristics of low cost and practicability.
6.The mRNA–miRNA–lncRNA Regulatory Network and Factors Associated with Prognosis Prediction of Hepatocellular Carcinoma
Hu BO ; Ma XIAOLU ; Fu PEIYAO ; Sun QIMAN ; Tang WEIGUO ; Sun HAIXIANG ; Yang ZHANGFU ; Yu MINCHENG ; Zhou JIAN ; Fan JIA ; Xu YANG
Genomics, Proteomics & Bioinformatics 2021;19(6):913-925
The aim of this study was to identify novel prognostic mRNA and microRNA (miRNA) biomarkers for hepatocellular carcinoma (HCC) using methods in systems biology. Differentially expressed mRNAs, miRNAs, and long non-coding RNAs (lncRNAs) were compared between HCC tumor tissues and normal liver tissues in The Cancer Genome Atlas (TCGA) database. Subsequently, a prognosis-associated mRNA co-expression network, an mRNA–miRNA reg-ulatory network, and an mRNA–miRNA–lncRNA regulatory network were constructed to identify prognostic biomarkers for HCC through Cox survival analysis. Seven prognosis-associated mRNA co-expression modules were obtained by analyzing these differentially expressed mRNAs. An expression module including 120 mRNAs was significantly corre-lated with HCC patient survival. Combined with patient survival data, several mRNAs and miRNAs, including CHST4, SLC22A8, STC2, hsa-miR-326, and hsa-miR-21 were identified from the network to predict HCC patient prognosis. Clinical significance was investigated using tissue microarray analysis of samples from 258 patients with HCC. Functional annotation of hsa-miR-326 and hsa-miR-21-5p indicated specific associations with several cancer-related pathways. The present study provides a bioinformatics method for biomarker screening, leading to the identification of an integrated mRNA–miRNA–lncRNA regulatory network and their co-expression patterns in relation to predicting HCC patient survival.
7.Identification on biological characteristics of AIV H5N1 monoclonal antibody
Jingli LI ; Haixiang ZHANG ; Yangmeng FENG ; Guanghua WANG ; Yongnian LIU ; Jun HU
Chinese Journal of Immunology 2017;33(3):398-400,406
Objective:To investigate the biological characteristics of monoclonal antibodies against avian influenza virus (AIV).Methods:Monoclonal antibodies (mAbs) against AIV H5N1 were prepared and it′s characteristics were identified including subtype,titer,hemagglutination inhibition activity and cross-reactivity with other influenza viruses.Besides,Western blot and immuno-histochemical staining methods were conducted to test the combination of antibodies and antigen ( H5N1 ) and human normal tissues.Results:Immunohistochemical analysis showed that 2 mAbs (H5-32 and H5-35) cross-reacted with human tissues kidney and pancreas respectively.Conclusion:These data indicated that there have some association between the AIV H 5N1 with human tissues, which may provide reference for the study on avian influenza virus infection and pathogenicity .
8.The effects treated with PICKCa rabies vaccine to mice and beagle dogs infected rabies wild viruses and volunteers immunized with PICKCa rabies vaccine
Haixiang LIN ; Gelin XU ; Jie WU ; Shoufeng ZHANG ; Rongliang HU ; Lietao LI ; Fang LIU ; Shirui ZHANG ; Yi ZHANG
Chinese Journal of Experimental and Clinical Virology 2016;(1):37-40
Objective To test the immune therapeutic effects of PICKCa adjuvant rabies vaccine for the post-exposure mice and beagle dogs and immune memory effect for human.Methods For the mice and beagle dogs first to infect with rabies wild virus and then immunize with PICKCa rabies vaccine.For volunteers, first to immunize with PICKCa rabies vaccine after 2.5 years to take peripheral blood mononuclear cell and then to check cells secreted interferon-gwith flow cytometry. Results In 3 independent assays of post-explosure immunization of mice and beagle dogs PICKCa rabies vaccine were much better then commercial adjuvant-free rabies vaccines, the protective rate from 20%-30%to 70%-100%Also, in the assay of cells secreted IFN-γby peripheral blood mononuclear cells from volunteers immunized by PICKCa rabies vaccine the IFN-γcell levels were much higher than control.Conclusions Compared with commercial adjuvant-free rabies vaccines the PICKCa rabies vaccine had significant immune therapeutic effects in the mice and dogs.Also PICKCa rabies vaccine had good immune memory effect in human.
9.AntiEGFRnano inhibites proliferation and migration of estrogen-dependent Ishikawa cells of human endometrial cancer cell line.
Zhenyu DIAO ; Wuguang LU ; Peng CAO ; Yunlong HU ; Xing ZHOU ; Pingping XUE ; Li SHEN ; Haixiang SUN
Acta Pharmaceutica Sinica 2012;47(10):1341-6
Nanobody is a kind of antibody from camel, which misses light chain. Nanobody has the same antigen binding specificity and affinity as mAb. Moreover, because of its small molecular weight, high stability and easy preparation, nanobody has great value of biomedical applications. In this study, we successfully prepared highly pure antiEGFR nanobody in E.coli using genetic engineering techniques. Cell proliferation assay (CCK-8 assay) and migration experiments (cell scratch test and Transwell assay) indicated that the recombinant antiEGFRnano can significantly inhibit the proliferation and migration of endometrial cancer cells. These results provide a new way of thinking and methods for EGFR-targeted therapy of endometrial cancer.
10.The correlation study on TCM body constitution classification and the reproductive system diseases in young man
Baomin JI ; Haixiang HU ; Shaobo LUO
International Journal of Traditional Chinese Medicine 2011;33(9):827-829
Objective To study the correlation between the body constitution classifications of traditional Chinese medicine (TCM)and the reproductive system diseases in young man. Methods All 749 objects took physical examination about the reproductive system diseases, filled in the questionnaire of male body constitution, and differentiated TCM classifications of body constitution. Results The incidence rate of redundant prepuce of depressed vital energy constitution and stagnant blood constitution was obviously higher than balance constitution (P<0.01) , the incidence rate of prostatitis of dampness-heat constitution and depressed vital energy constitution was obviously higher than balance constitution (P<0.01), the incidence rate of varicocele of Qi asthonia constitution and stagnant blood constitution was obviously higher than balance constitution(P<0.01), the incidence rate of phimosis of Yang deficiency constitution was obviously higher than balance constitution (P<0.01) , the incidence rote of prospermia of Qi asthenia constitution, Yin deficiency constitution and special constitution was obviously higher than balance constitution (P<0.01) , the incidence rate of erectile dysfunction of Yin deficiency constitution and special constitution was obviously higher than balance constitution (P<0.01) , the incidence rate of sterility of Yang deficiency consZtitution, Yin deficiency constitution and stagnant blood constitution was obviously higher than balance constitution (P<0.01) .Conclusion There were some correlations between the TCM classifications of body constitution and the reproductive system diseases in young man.

Result Analysis
Print
Save
E-mail